Metabolomics and in-vitro bioactivities studies of fermented Musa paradisiaca pulp : apotential alpha-amylase inhibitor

Show simple item record

dc.contributor.author Atunnise, Adeleke Kazeem
dc.contributor.author Bodede, Olusola
dc.contributor.author Adewuyi, Adewale
dc.contributor.author Maharaj, Vinesh J.
dc.contributor.author Prinsloo, Gerhard
dc.contributor.author Salau, Bamidele Adewale
dc.date.accessioned 2024-06-24T13:17:28Z
dc.date.available 2024-06-24T13:17:28Z
dc.date.issued 2024-02
dc.description.abstract The in-vitro synthesis of bio-compounds via fermentation is a promising route for bioactive molecules intended for disease control and management. Therefore, this study evaluated the effect of fermentation on the antioxidants, antihyperglycemic and anti-inflammatory properties and the resultant chemometric phytochemical profiles of unripe plantain fruits. The results revealed that Escherichia coli and Propionibacterium spp. are suspected as the key fermenters. The E coli showed negative results to the pathogenicity test; Propionibacterium appeared to be opportunistic. A significant increase in the total polyphenols and protein and decreased flavonoids was recorded in the phytochemical profile of the methanolic extract of the fermented unripe plantain pulp; however, the ascorbic acid content was not significantly altered. The 1H NMR fingerprint showed that there is a closely related chemical shift among the shorter fermentation time (days 2–6) and the unfermented, while the more extended fermentation periods (days 7–12) with enhanced bioactivities were closely related based on the chemometrics analyses. Furthermore, the UPLC-QTOF-MS analysis annotated the presence of bioactive compounds in the day-9 fermented sample: polyhydroxy glucose conjugates (3-Methoxy-4-hydroxyphenyl 6-O-(3,4,5-trihydroxybenzoyl)-beta-D-glucopyranoside), short chain peptide (leucyl-glycyl-glycine), amino acid derivatives (4-Aminophenylalanine, and N-Acetylhistidine), linear and cyclic fatty acid derivatives (palmitoyl putrescine, ricinoleic acid, phytosphingosine, gabalid, rubrenoic acid, 2-aminocyclopentanecarboxylic and cystodienioc acid). The synergistic effect of these newly formed compounds and the increase in the phenolic content of the day-9 fermented unripe plantain may account for its more potent antioxidant, anti-inflammatory and antihyperglycemic activity. Therefore, the products obtained from the day 9 fermentation of unripe plantain pulp may serve as potential nutraceutical agents against gastro-enteric sugar digestion and absorption and sugar-induced oxidative stress, inflammation and metabolic disease. en_US
dc.description.department Chemistry en_US
dc.description.librarian hj2024 en_US
dc.description.sdg SDG-02:Zero Hunger en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.uri https://www.cell.com/heliyon en_US
dc.identifier.citation Atunnise, A.K., Bodede, O., Adewuyi, A. et al. 2024, 'Metabolomics and in-vitro bioactivities studies of fermented Musa paradisiaca pulp: a potential alpha-amylase inhibitor', Heliyon, vol. 10, no. 3, art. e24659, pp. 1-17, doi : 10.1016/j.heliyon.2024.e24659. en_US
dc.identifier.issn 2405-8440 (online)
dc.identifier.other 10.1016/j.heliyon.2024.e24659
dc.identifier.uri http://hdl.handle.net/2263/96615
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.rights © 2024 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license. en_US
dc.subject Antioxidants en_US
dc.subject Diabetes mellitus en_US
dc.subject Fermentation en_US
dc.subject Metabolomics en_US
dc.subject Inflammation en_US
dc.subject Unripe-plantain pulp en_US
dc.subject SDG-03: Good health and well-being en_US
dc.subject SDG-02: Zero hunger en_US
dc.title Metabolomics and in-vitro bioactivities studies of fermented Musa paradisiaca pulp : apotential alpha-amylase inhibitor en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record